Therefore, recent studies suggest that blood NfL predicts motor and cognitive decline in PD patients, which lays ground for an individualized prognosis and treatments of PD patients (Lin et al. 2019; Niemann et al. 2021). This evidence concerns the gene NEFL and Parkinson disease.